Analysis of Brain Structures

Automated segmentation of brain structures & quantification of major volumes
Comparison of patient’s brain metrics to a reference database of more than 2000 healthy subjects
Advanced data visualization for atrophy and disease activity assessment – longitudinal charts and 3D rendering
Compliant with gold standard brain MRI protocols (ACR, ADNI, OFSEP) – large range of acquisition parameters for T1, T2, FLAIR sequencies
Vendor-neutral - MRI systems, PACS, viewer
Integration into information systems (DICOM protocols & standards) and clinical workflow
Smart reporting – automated and standardized data sent to the radiology report (DICOM SR, FIHR standards)
Validated on a large memory clinic population cohort of 2000 patients

Aims to promote early diagnosis - automated quantification of atrophy subtypes by lobe (limbic-predominant, hippocampal sparing, typical/diffuse), providing early prognostic value from the MCI stage regarding the severity and type of future cognitive and functional decline.
Progression monitoring - visualization of WMH dissemination in time and space supporting continued monitoring of patients' response to treatment.
May further clinical decision confidence supporting more personalized therapeutic intervention.
Brings tools to the practitioner that can improve patient information and hence, satisfaction.
For Alzheimer's disease & other Dementias QyScore® can increase diagnosis confidence, support clinical decision making and early intervention.
For multiple sclerosis, QyScore® supports the individualized monitoring of disease evolution and treatment plan efficacy, helping drive potential improvement of healthcare outcomes.
For Parkinson’s disease, QyScore® have the potential to help facilitate a more precise differential diagnosis with other movement disorders such as Progressive Supranuclear Palsy (PSP)

QyScore®